Shandong Sinobioway Biomedicine Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.043x

Shandong Sinobioway Biomedicine Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shandong Sinobioway Biomedicine Co Ltd (002581) has a cash flow conversion efficiency ratio of -0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-86.58 Million ≈ $-12.67 Million USD) by net assets (CN¥1.99 Billion ≈ $291.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shandong Sinobioway Biomedicine Co Ltd (2007–2025)

Cash flow conversion efficiency of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025. This chart illustrates how Shandong Sinobioway Biomedicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Sinobioway Biomedicine Co Ltd share price for real-time trading data and today's change.

Shandong Sinobioway Biomedicine Co Ltd Cash Flow Conversion Ratio Explained

Shandong Sinobioway Biomedicine Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shandong Sinobioway Biomedicine Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Sinobioway Biomedicine Co Ltd ranked by their cash flow conversion efficiency. Also see Shandong Sinobioway Biomedicine Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Assembly Biosciences Inc
NASDAQ:ASMB
-0.051x
WA1 Resources Ltd
AU:WA1
0.004x
Youngy Health Co Ltd
SHE:300247
-0.015x
Bin Chuan Enterprise Co Ltd
TWO:1569
-0.024x
NH SPAC 8
KQ:225570
-0.014x
Jiangxi Synergy Pharmaceutical Co Ltd
SHE:300636
0.027x
Shanghai Xuerong Bio-Technology Co Ltd
SHE:300511
-0.053x
Shanghai Yahong Moulding Co Ltd
SHG:603159
0.056x

Annual Cash Flow Conversion Efficiency for Shandong Sinobioway Biomedicine Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025. Review Shandong Sinobioway Biomedicine Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.95 Billion
≈ $284.82 Million
CN¥-253.73 Million
≈ $-37.13 Million
-0.130x -3926.70%
2024-12-31 CN¥2.02 Billion
≈ $295.93 Million
CN¥-6.55 Million
≈ $-958.04K
-0.003x +80.72%
2023-12-31 CN¥2.17 Billion
≈ $318.08 Million
CN¥-36.51 Million
≈ $-5.34 Million
-0.017x +23.91%
2022-12-31 CN¥2.47 Billion
≈ $361.21 Million
CN¥-54.49 Million
≈ $-7.97 Million
-0.022x -18.45%
2021-12-31 CN¥2.47 Billion
≈ $361.34 Million
CN¥-46.02 Million
≈ $-6.73 Million
-0.019x -320.54%
2020-12-31 CN¥2.19 Billion
≈ $320.56 Million
CN¥18.51 Million
≈ $2.71 Million
0.008x -58.31%
2019-12-31 CN¥2.39 Billion
≈ $349.56 Million
CN¥48.41 Million
≈ $7.08 Million
0.020x -23.24%
2018-12-31 CN¥2.82 Billion
≈ $412.66 Million
CN¥74.46 Million
≈ $10.90 Million
0.026x -71.58%
2017-12-31 CN¥2.92 Billion
≈ $427.04 Million
CN¥271.11 Million
≈ $39.67 Million
0.093x +38.67%
2016-12-31 CN¥2.53 Billion
≈ $369.84 Million
CN¥169.32 Million
≈ $24.78 Million
0.067x +4.28%
2015-12-31 CN¥2.14 Billion
≈ $313.71 Million
CN¥137.73 Million
≈ $20.15 Million
0.064x -39.90%
2014-12-31 CN¥749.40 Million
≈ $109.66 Million
CN¥80.11 Million
≈ $11.72 Million
0.107x -5.07%
2013-12-31 CN¥738.31 Million
≈ $108.04 Million
CN¥83.13 Million
≈ $12.16 Million
0.113x +25.83%
2012-12-31 CN¥704.41 Million
≈ $103.08 Million
CN¥63.04 Million
≈ $9.22 Million
0.089x -19.17%
2011-12-31 CN¥672.28 Million
≈ $98.38 Million
CN¥74.43 Million
≈ $10.89 Million
0.111x -77.09%
2010-12-31 CN¥177.34 Million
≈ $25.95 Million
CN¥85.71 Million
≈ $12.54 Million
0.483x +15.97%
2009-12-31 CN¥129.71 Million
≈ $18.98 Million
CN¥54.06 Million
≈ $7.91 Million
0.417x +3.22%
2008-12-31 CN¥116.12 Million
≈ $16.99 Million
CN¥46.89 Million
≈ $6.86 Million
0.404x +35.21%
2007-12-31 CN¥83.94 Million
≈ $12.28 Million
CN¥25.07 Million
≈ $3.67 Million
0.299x --

About Shandong Sinobioway Biomedicine Co Ltd

SHE:002581 China Drug Manufacturers - Specialty & Generic
Market Cap
$404.50 Million
CN¥2.76 Billion CNY
Market Cap Rank
#13032 Global
#3813 in China
Share Price
CN¥4.19
Change (1 day)
+1.70%
52-Week Range
CN¥3.10 - CN¥8.75
All Time High
CN¥39.86
About

Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. It offers injectable mouse nerve growth factor, human interferon, vaccines, traditional Chinese medicine decoction pieces, and pharmaceutical distribution. The company was founded in 1998 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Y… Read more